IBO (Impact BioMedical) Operating Cash Flow per Share : $-0.26 (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Operating Cash Flow per Share?

Impact BioMedical's operating cash flow per share for the three months ended in Mar. 2025 was $-0.06. Impact BioMedical's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.26.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -114.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Impact BioMedical's Operating Cash Flow per Share or its related term are showing as below:

IBO' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -169.2 Med: -141.75 Max: -114.3
Current: -114.3

During the past 6 years, Impact BioMedical's highest 3-Year average Operating Cash Flow per Share Growth Rate was -114.30% per year. The lowest was -169.20% per year. And the median was -141.75% per year.

IBO's 3-Year OCF Growth Rate is ranked worse than
98.36% of 1218 companies
in the Biotechnology industry
Industry Median: 9.1 vs IBO: -114.30

Impact BioMedical Operating Cash Flow per Share Historical Data

The historical data trend for Impact BioMedical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Operating Cash Flow per Share Chart

Impact BioMedical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.04

-0.20

-0.05

-0.36

Impact BioMedical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.04	-0.08	-0.02	-0.11	-0.06

Competitive Comparison of Impact BioMedical's Operating Cash Flow per Share

For the Biotechnology subindustry, Impact BioMedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impact BioMedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Impact BioMedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Impact BioMedical's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Impact BioMedical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Impact BioMedical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-3.919	/	10.757
	=	-0.36

Impact BioMedical's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-0.682	/	12.063
	=	-0.06

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26

Impact BioMedical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Impact BioMedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084

Website

https://www.impactbiomedinc.com

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Impact BioMedical Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024